University of Western Australia life sciences spin-out iCeutica has its lead drug approved by the FDA.
The US-based Food and Drug Administration has approved Zorvolex, an anti-inflammatory drug to treat acute pain developed by University of Western Australia (UWA) spin-out iCeutica. The life sciences firm, which was acquired by investors linked to US partner Iroko Pharmaceuticals in 2011, has been developing the drug based on submicron-sized particles since it was founded…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
